Websites hosted on 165.89.235.20 IP Address
Geo Location Information for 165.89.235.20 IP Address. The IP Address 165.89.235.20 is located at 37.751 latitude and -97.822 longitude in United States of America. Friendly Location for the IP Address is United States.
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Physician and Staff Resources | Rx ELIQUIS® (apixaban)
See benefits and risks, including Boxed WARNINGS. Request Rx ELIQUIS® samples and get resources for HCPs and Patients.
Physician and Staff Resources | Rx ELIQUIS® (apixaban)
See benefits and risks, including Boxed WARNINGS. Request Rx ELIQUIS® samples and get resources for HCPs and Patients.
DNS resolution error | www.my-multiple-sclerosis.com | Cloudflare
DNS resolution error | www.my-multiple-sclerosis.org | Cloudflare
Bristol Myers Squibb – globalna firma biofarmaceutyczna
Dowiedz się więcej o Bristol Myers Squibb i naszej misji – odkrywaniu i opracowywaniu innowacyjnych leków, które pomagają pacjentom przezwyciężać poważne choroby.
Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol-Myers Squibb Medizinische Information Online
Medizinische Information Online – eine Suchmöglichkeit für medizinische Fachkreise nach medizinisch-wissenschaftlichen Informationen im Zusammenhang mit Arzneimitteln von Bristol-Myers Squibb
Bristol Myers Squibb - Παγκόσμια βιοφαρμακευτική εταιρεία
Μάθετε περισσότερα για την Bristol-Myers Squibb και την αποστολή μας, η οποία εστιάζει στην ανακάλυψη, ανάπτυξη και διάθεση καινοτόμων φαρμάκων στους ασθενείς που πάσχουν από σοβαρές ασθένειες.
Bristol Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.